Evidence map›Paper›PMID 38946725›Full record

ArticleJournal of cell communication and signaling2024

TM4SF1 is a molecular facilitator that distributes cargo proteins intracellularly in endothelial cells in support of blood vessel formation.

Chi-Iou Lin, Anne Merley, Shou-Ching S Jaminet

Abstract read
In one paragraph

Article in Journal of cell communication and signaling, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Chi-Iou LinCenter for Vascular Biology Research and Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston Massachusetts USA.
Anne MerleyCenter for Vascular Biology Research and Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston Massachusetts USA.
Shou-Ching S JaminetCenter for Vascular Biology Research and Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston Massachusetts USA.ORCID https://orcid.org/0009-0003-6358-7574

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transmembrane-4 L-six family member-1 (TM4SF1) is an atypical tetraspanin that is highly and selectively expressed in proliferating endothelial cells and plays an essential role in blood vessel development. TM4SF1 forms clusters on the cell surface called TMED (TM4SF1-enriched microdomains) and recruits other proteins that internalize along with TM4SF1 via microtubules to intracellular locations including the nucleus. We report here that tumor growth and wound healing are inhibited in

Indexed as

angiogenesisHDAC6PLCγprotein traffickingTM4SF1‐mediated endocytosis

Identifiers

PMID38946725
PMCPMC11208120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.